GO:0004911 interleukin-2 receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004911 (interleukin-2 receptor activity) is a molecular function defined as combining with interleukin-2 and transmitting the signal across the membrane to initiate a change in cell activity.
• The interleukin-2 receptor (IL-2R) is a multi-subunit complex; signaling competence depends on the cooperative assembly of alpha, beta, and common gamma chain subunits.
• IL-2R signaling is central to T-cell proliferation, survival, and effector differentiation, making it a key node in immune regulation.
• Soluble IL-2R levels in serum are widely used as a clinical biomarker for immune activation in cancer, autoimmune disease, and inflammatory conditions.
• Dysregulated IL-2R activity is implicated in leukemia, lymphoma, autoimmune disorders, and transplant rejection.
• CRISPR-based knockout, knock-in, and point-mutation models enable precise dissection of IL-2R subunit contributions to signaling and disease.
Description
Interleukin-2 receptor activity (GO:0004911) is the molecular function by which a cell binds interleukin-2 (IL-2) and converts that binding event into an intracellular signal that alters cell behavior. This activity is essential for the proper function of the immune system, particularly for T lymphocytes, and its dysregulation is associated with a broad spectrum of human diseases. Understanding the precise molecular architecture and signaling mechanisms of the IL-2 receptor is therefore a fundamental goal in immunology and clinical research. The receptor is not a single protein but a complex of subunits that together achieve high-affinity binding and signal transduction. The alpha chain (IL2RA, CD25) confers high affinity, while the beta chain (IL2RB, CD122) and the common gamma chain (IL2RG, CD132) are responsible for signal transmission. This multi-subunit arrangement allows for tight regulation of IL-2 responsiveness, which is critical for maintaining immune homeostasis and preventing autoimmunity. Because of its central role in immune activation, the IL-2 receptor and its soluble forms have become important biomarkers and therapeutic targets. Research into GO:0004911 spans molecular biology, structural biology, and clinical diagnostics, and is supported by a wide array of experimental models including CRISPR-engineered cell lines.
interleukin-2 receptor activity At A Glance
| GO ID | GO:0004911 |
|---|---|
| GO term | interleukin-2 receptor activity |
| Ontology | molecular_function |
| Synonym | IL-2R, IL-2 receptor activity |
| Definition | Combining with interleukin-2 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. |
| Major function | Binds interleukin-2 and initiates intracellular signaling, primarily in immune cells. |
| Key subunits | IL2RA (CD25), IL2RB (CD122), IL2RG (CD132) |
| Primary ligands | Interleukin-2 (IL-2) |
| Associated diseases | Leukemia, lymphoma, autoimmune diseases, transplant rejection |
What Is GO:0004911?
In simple terms, interleukin-2 receptor activity is the ability of a cell surface receptor to grab interleukin-2 and pass a signal into the cell that changes what the cell does. According to the Gene Ontology, this activity is defined as combining with interleukin-2 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. This function is carried out by a receptor complex that includes the IL-2 receptor alpha, beta, and gamma chains, which work together to bind the ligand and activate downstream signaling pathways.
Why Is interleukin-2 receptor activity Important in Cell Biology?
Interleukin-2 receptor activity is a cornerstone of adaptive immunity because it controls the magnitude and duration of T-cell responses. Without proper IL-2R signaling, T cells fail to proliferate and survive, leading to immunodeficiency, while excessive or inappropriate signaling can drive autoimmunity and hematological malignancies. The receptor's soluble form is a clinically validated biomarker for immune activation, used in the management of conditions such as familial breast cancer, idiopathic retroperitoneal fibrosis, juvenile idiopathic arthritis, and canine lymphoma. Consequently, studying GO:0004911 is essential for understanding immune regulation, developing targeted immunotherapies, and improving diagnostic strategies.
• Controls T-cell proliferation, survival, and effector function, making it central to adaptive immunity.
• Dysregulation is linked to autoimmune diseases such as juvenile idiopathic arthritis and idiopathic retroperitoneal fibrosis.
• Soluble IL-2R is a prognostic and predictive biomarker in familial breast cancer and lymphoma.
• Mutations in IL2RG cause severe combined immunodeficiency (SCID) by abolishing IL-2R signaling.
• IL-2R is a target for immunosuppressive therapies in transplant rejection and autoimmune disorders.
• Provides a model system for studying cytokine receptor assembly and signal transduction.
• Enables research into JAK-STAT pathway regulation and its role in hematological malignancies.
• Supports development of engineered T cells for cancer immunotherapy.
• Serves as a paradigm for multi-subunit receptor cooperativity and affinity modulation.
• Facilitates CRISPR-based functional genomics screens for immune regulators.
Core Biology of interleukin-2 receptor activity
Ligand Binding and Receptor Assembly
In simple terms: IL-2 first attaches to one subunit of the receptor, which then recruits the other subunits to form a complete signaling complex.
Interleukin-2 receptor activity begins with the binding of IL-2 to the IL-2 receptor alpha chain (IL2RA, CD25), which alone provides low-affinity binding. This initial interaction facilitates the recruitment of the beta chain (IL2RB, CD122) and the common gamma chain (IL2RG, CD132), forming a high-affinity heterotrimeric complex. The assembly of this complex is a prerequisite for signal transduction across the membrane.
Signal Transduction via JAK-STAT Pathway
In simple terms: Once the receptor subunits are together, they activate enzymes inside the cell that carry the signal to the nucleus.
The cytoplasmic domains of IL2RB and IL2RG are associated with Janus kinases (JAK1 and JAK3, respectively). Upon ligand-induced receptor assembly, these kinases phosphorylate each other and the receptor cytoplasmic tails, creating docking sites for STAT proteins, particularly STAT5. Phosphorylated STAT5 translocates to the nucleus and regulates transcription of genes involved in T-cell proliferation and survival.
Regulation of Signaling Intensity and Duration
In simple terms: The cell has built-in brakes to prevent the IL-2 signal from staying on too long.
IL-2R signaling is tightly regulated by multiple mechanisms, including receptor internalization, degradation, and the induction of negative feedback regulators such as SOCS proteins. The strength and duration of the signal are critical for determining T-cell fate, with transient signals favoring effector differentiation and sustained signals promoting memory or regulatory T-cell phenotypes.
Soluble IL-2 Receptor as a Biomarker
In simple terms: A piece of the receptor can be shed into the blood, where its levels reflect immune activation.
Proteolytic cleavage of the IL-2 receptor alpha chain generates soluble IL-2R (sIL-2R), which can be measured in serum. Elevated sIL-2R levels are observed in various inflammatory and malignant conditions, including familial breast cancer, idiopathic retroperitoneal fibrosis, juvenile idiopathic arthritis, and canine lymphoma, making it a useful clinical biomarker.
Key Genes Involved in GO:0004911 interleukin-2 receptor activity
The following genes encode the subunits and signaling components of the interleukin-2 receptor complex and its downstream pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL2RA | Alpha subunit of IL-2 receptor; confers high-affinity binding | Target for knockout to study affinity modulation; biomarker sIL-2R source |
| IL2RB | Beta subunit; essential for signal transduction | Knockout models reveal loss of T-cell proliferation |
| IL2RG | Common gamma chain; shared by multiple cytokine receptors | Mutations cause X-linked SCID; key for immunodeficiency research |
| JAK1 | Janus kinase associated with IL2RB | Phosphorylates STAT proteins; target for kinase inhibitors |
| JAK3 | Janus kinase associated with IL2RG | Mutations cause SCID; drug target for immunosuppression |
| STAT5A | Transcription factor downstream of IL-2R | Mediates gene expression for T-cell survival |
| STAT5B | Transcription factor downstream of IL-2R | Redundant with STAT5A; knockout affects Treg function |
| IL2 | Ligand for IL-2 receptor | Cytokine used to expand T cells in immunotherapy |
| SOCS1 | Negative regulator of cytokine signaling | Feedback inhibitor of IL-2R signaling |
| SOCS3 | Negative regulator of cytokine signaling | Modulates JAK-STAT pathway |
| PTPN2 | Protein tyrosine phosphatase | Dephosphorylates JAKs; regulates IL-2 sensitivity |
| CD25 | Alternative name for IL2RA | Marker for regulatory T cells |
| CD122 | Alternative name for IL2RB | Marker for memory T cells and NK cells |
| CD132 | Alternative name for IL2RG | Common gamma chain; target for gene therapy |
| FOXP3 | Transcription factor in regulatory T cells | IL-2R signaling maintains Treg suppressive function |
| BCL2 | Anti-apoptotic protein | Induced by IL-2R signaling to promote T-cell survival |
| MCL1 | Anti-apoptotic protein | Contributes to IL-2-dependent survival |
| CCND2 | Cell cycle regulator | Drives IL-2-induced proliferation |
How Is interleukin-2 receptor activity Regulated?
Interleukin-2 receptor activity is regulated at multiple levels, including receptor subunit expression, ligand availability, and intracellular feedback loops. The expression of IL2RA (CD25) is rapidly induced upon T-cell activation, while IL2RB and IL2RG are constitutively expressed on many immune cells. Signaling is terminated by internalization and degradation of the receptor complex, as well as by the induction of SOCS proteins that inhibit JAK kinase activity. Additionally, phosphatases such as PTPN2 can dephosphorylate JAKs and STATs, dampening the signal. The balance between activating and inhibitory signals determines the functional outcome of IL-2R engagement.
interleukin-2 receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL2RG | X-linked severe combined immunodeficiency (SCID) | Knockout mice or human iPSC-derived T cells |
| IL2RA | Autoimmune disease, lymphoma biomarker | CRISPR knockout in Jurkat T cells |
| JAK3 | SCID, autoimmune disorders | Point-mutation knock-in in cell lines |
| STAT5B | Immune dysregulation, lymphoma | Overexpression in primary T cells |
| IL2RB | T-cell immunodeficiency, autoimmunity | Knock-in reporter for signaling dynamics |
IL-2 Receptor in Hematological Malignancies
Dysregulated IL-2 receptor signaling contributes to the pathogenesis of leukemias and lymphomas. Constitutive activation of JAK-STAT pathways downstream of IL-2R can drive uncontrolled proliferation of T cells. In canine lymphoma, serum IL-2 receptor levels have been evaluated as a prognostic factor, highlighting its translational relevance.
Autoimmune and Inflammatory Conditions
Elevated soluble IL-2 receptor levels are observed in autoimmune diseases such as juvenile idiopathic arthritis and idiopathic retroperitoneal fibrosis, where they correlate with disease activity and relapse risk. This reflects excessive immune activation driven by IL-2R signaling.
Immunodeficiency and Cancer Predisposition
Mutations in IL2RG cause X-linked severe combined immunodeficiency (SCID), characterized by absent T and NK cell function. In familial breast cancer, soluble IL-2 receptor has been investigated as a predictive and prognostic marker, suggesting a role in cancer-related immune dysregulation.
From interleukin-2 receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of IL2RA abolish high-affinity IL-2 binding? | IL2RA knockout cell line (e.g., Jurkat) |
| How does a specific JAK3 mutation affect IL-2R signaling? | Point-mutation knock-in in HEK293T or T cells |
| Can a tagged IL2RB reveal receptor trafficking? | Knock-in of fluorescent tag at endogenous locus |
| Does overexpression of STAT5B drive proliferation? | Overexpression cell model in primary T cells |
| What genes are essential for IL-2R signaling? | Genome-wide CRISPR knockout library screen |
| How does IL2RG mutation affect NK cell development? | iPSC-derived NK cells with IL2RG knockout |
How to Study the interleukin-2 receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify IL-2-induced transcriptional programs |
| Phosphoproteomics | Phosphorylation of signaling proteins | Map JAK-STAT activation kinetics |
| Flow cytometry | Surface expression of IL-2R subunits | Characterize T-cell subsets and activation states |
| CFSE dilution | Cell proliferation | Assess IL-2-dependent T-cell expansion |
| Annexin V staining | Apoptosis | Measure IL-2-dependent survival |
| FRET microscopy | Receptor subunit proximity | Visualize IL-2R assembly in live cells |
| ELISA | Soluble IL-2R levels | Clinical biomarker measurement |
| CRISPR screen | Gene essentiality for IL-2R signaling | Identify novel regulators |
Transcriptomic Analysis of IL-2R Signaling
RNA sequencing (RNA-seq) can be used to profile gene expression changes following IL-2 stimulation, revealing downstream targets of STAT5 and other transcription factors. This method is useful for identifying signatures of T-cell activation and differentiation.
Proteomic and Phosphoproteomic Profiling
Mass spectrometry-based proteomics can quantify phosphorylation events on IL-2R subunits and downstream signaling molecules, providing a global view of signal transduction dynamics. This approach helps identify novel regulators and feedback mechanisms.
Flow Cytometry and Imaging
Flow cytometry is routinely used to measure surface expression of IL-2R subunits (CD25, CD122, CD132) on immune cells. Advanced imaging techniques such as FRET or super-resolution microscopy can visualize receptor assembly and internalization in real time.
Functional Assays for T-cell Proliferation and Survival
Proliferation assays (e.g., CFSE dilution) and apoptosis assays (e.g., Annexin V staining) are used to assess the functional consequences of IL-2R activity. These assays are critical for validating findings from genetic screens.
How CRISPR Can Be Used to Study GO:0004911 interleukin-2 receptor activity
Knockout
CRISPR knockout of IL2RA, IL2RB, or IL2RG in T-cell lines or primary cells can abolish IL-2R activity, providing a clean background to study subunit-specific functions. Such models are valuable for validating drug targets and understanding immunodeficiency mechanisms.
Point Mutation
Introducing specific point mutations (e.g., in JAK3 or IL2RG) via CRISPR base editing or homology-directed repair allows researchers to model patient-derived mutations and dissect signaling domain requirements. These models can reveal how single amino acid changes affect receptor function.
Knock-in
Knock-in of fluorescent or epitope tags at the endogenous IL2RA or IL2RB locus enables real-time tracking of receptor expression, localization, and trafficking without overexpression artifacts. This approach is ideal for studying receptor dynamics in primary immune cells.
Overexpression
CRISPR-mediated overexpression (e.g., via CRISPRa) of IL2RA or downstream effectors like STAT5B can model gain-of-function states observed in malignancies and autoimmune diseases. Overexpression models help identify oncogenic drivers and test targeted inhibitors.
How EDITGENE Supports interleukin-2 receptor activity Research
Researchers studying interleukin-2 receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor function, signaling, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation and accelerating translational research.
Contact EDITGENE today to design your custom CRISPR model for interleukin-2 receptor activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| IL2RA Knockout HEK293 Cell Line | EDJ-KQ493 | Human | 3559 | Details Get a Quote |
| IL2RB Knockout HEK293 Cell Line | EDJ-KQ494 | Human | 3560 | Details Get a Quote |
| IL2RG Knockout HEK293 Cell Line | EDJ-KQ495 | Human | 3561 | Details Get a Quote |
| IL2RA Knockout HeLa Cell Line | EDJ-KQ53631 | Human | 3559 | Details Get a Quote |
| IL2RB Knockout HeLa Cell Line | EDJ-KQ53632 | Human | 3560 | Details Get a Quote |
| IL2RG Knockout HeLa Cell Line | EDJ-KQ53633 | Human | 3561 | Details Get a Quote |
| IL2RA Knockout A-549 Cell Line | EDJ-KQ62106 | Human | 3559 | Details Get a Quote |
| IL2RB Knockout A-549 Cell Line | EDJ-KQ62107 | Human | 3560 | Details Get a Quote |
| IL2RG Knockout A-549 Cell Line | EDJ-KQ62108 | Human | 3561 | Details Get a Quote |
| IL2RA Knockout HCT 116 Cell Line | EDJ-KQ70593 | Human | 3559 | Details Get a Quote |
| IL2RB Knockout HCT 116 Cell Line | EDJ-KQ70594 | Human | 3560 | Details Get a Quote |
| IL2RG Knockout HCT 116 Cell Line | EDJ-KQ70595 | Human | 3561 | Details Get a Quote |
Displaying Records 1 To 12 Of 12 Records
Frequently Asked Questions About interleukin-2 receptor activity
What is interleukin-2 receptor activity?
Interleukin-2 receptor activity (GO:0004911) is the molecular function of binding interleukin-2 and transmitting a signal across the cell membrane to initiate changes in cell activity.
What genes are involved in interleukin-2 receptor activity?
Key genes include IL2RA, IL2RB, IL2RG, JAK1, JAK3, STAT5A, and STAT5B, which encode the receptor subunits and downstream signaling molecules.
What diseases are associated with interleukin-2 receptor activity?
Dysregulation is linked to leukemias, lymphomas, autoimmune diseases like juvenile idiopathic arthritis, and immunodeficiency such as X-linked SCID.
How is interleukin-2 receptor activity measured?
It can be measured by flow cytometry for surface subunits, phospho-STAT5 assays, proliferation assays, and serum soluble IL-2R ELISA.
What is the role of soluble IL-2 receptor?
Soluble IL-2R is a shed form of the alpha chain used as a biomarker for immune activation in cancer, autoimmune disease, and inflammatory conditions.
Can CRISPR be used to study interleukin-2 receptor activity?
Yes, CRISPR knockout, knock-in, and point mutation models allow precise dissection of IL-2R subunit functions and signaling pathways.
What is the difference between IL2RA, IL2RB, and IL2RG?
IL2RA (CD25) confers high-affinity ligand binding, while IL2RB (CD122) and IL2RG (CD132) are responsible for signal transduction.
Which signaling pathway is activated by IL-2 receptor?
The JAK-STAT pathway, particularly JAK1/JAK3 and STAT5, is the primary signaling cascade downstream of IL-2R.
Why is IL-2 receptor important in cancer?
Constitutive IL-2R signaling can drive T-cell malignancies, and soluble IL-2R is a prognostic marker in breast cancer and lymphoma.
What model systems are used to study IL-2 receptor activity?
Common models include Jurkat T cells, primary T cells, HEK293T cells, and iPSC-derived immune cells, often engineered with CRISPR.
Conclusion
Interleukin-2 receptor activity (GO:0004911) is a fundamental molecular function that governs immune cell activation, proliferation, and survival. Its multi-subunit architecture and tight regulation ensure appropriate immune responses, while its dysregulation contributes to a range of diseases from immunodeficiency to cancer and autoimmunity. Continued research using advanced CRISPR models and clinical biomarkers will further elucidate its roles and unlock new therapeutic opportunities.
References
- 1. Gaffen SL. 2001. Signaling domains of the interleukin 2 receptor.. Cytokine 14(2):63-77 PMID: 11356007
- 2. Smith KA. 1988. The interleukin 2 receptor.. Adv Immunol 42:165-79 PMID: 3129919
- 3. Greene WC et al.. 1986. The human interleukin-2 receptor.. Annu Rev Immunol 4:69-95 PMID: 3011033
- 4. Gonda K et al.. 2021. Soluble interleukin-2 receptor as a predictive and prognostic marker for patients with familial breast cancer.. Sci Prog 104(3):368504211039590 PMID: 34559590
- 5. Kharagjitsing HHS et al.. 2022. Clinical significance of soluble interleukin-2 receptor measurement in patients with idiopathic retroperitoneal fibrosis.. Int Urol Nephrol 54(10):2663-2671 PMID: 35359217
- 6. Ziegler L et al.. 2022. Soluble interleukin-2 receptor serum levels facilitate prediction of relapses in subgroups of patients with juvenile idiopathic arthritis.. Rheumatology (Oxford) 61(12):4975-4984 PMID: 35325053
- 7. Im JH et al.. 2023. Evaluation of serum interleukin 2 receptor and beta-2-microglobulin as prognostic factors for canine lymphoma: A pilot study.. Vet Comp Oncol 21(2):184-190 PMID: 36635848
- 8. Kolitz JE et al.. 1985. Interleukin 2: a review.. Arzneimittelforschung 35(10):1607-15 PMID: 3000391
